Efficacy of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis
Main Article Content
Keywords
epilepsy, infants, ketogenic diet therapy
Abstract
Introduction: The ketogenic diet therapy, a high-fat, low-carbohydrate diet, has been known since the 1920s as a therapeutic option in treating drug-resistant epilepsy. However, with the increasing incidence of the infant population, research on this subject is still limited. This systematic review and meta-analysis aimed to evaluate the efficacy of ketogenic diet therapy in infants with epilepsy.
Methods: We searched the articles from Cochrane Library, Embase, Pubmed, ScienceDirect, and Scopus, based on predetermined inclusion criteria. Four investigators independently performed screening, study selection, extracted data, and assessed the quality of relevant articles. We used the Newcastle-Ottawa Quality Assessment Scale to assess the risk of bias in included articles. We present the results of the meta-analysis using a forest plot.
Results: We identified 1781 studies from database screening, with eight cohort studies in this study. Our meta-analysis revealed that an estimate of 69% of infants with epilepsy achieved ≥50% seizure reduction in three months follow-up (95% confidence interval [CI] 56- 82%) and an estimate of 36% of infants achieved seizure freedom (95% confidence interval [CI] 20- 51%). Retention rates ranged from 91% at three months to 28% at 24 months. The most common side effects reported were dyslipidemia (131/355, 36.9%), gastrointestinal disturbances (66/355, 18.6%), and hyperkeratosis/acidosis (42/355, 11.8%).
Conclusion: Ketogenic diet therapy is well tolerated and effectively reduces seizure frequency at three months in infants with epilepsy.
References
2. Knupp K, Koh S, Park K. Pediatric epilepsy. Neurol Clin Pract. 2012 Mar; 2(1): 40–47.
3. Minardi C et al. Epilepsy in children: from diagnosis to treatment with focus on emergency. J Clin Med. 2019 Jan; 8(1): 39.
4. Kumar G. Evaluation and management of drug-resistant epilepsy in children. Current Problems in Pediatric and Adolescent Health Care. 2012 Jul;51(7):1-10
5. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-77
6. Ko A, Kwon HE, Kim HD. Updates on ketogenic diet therapy for pediatric epilepsy. Biomedical Journal. 2022 Feb; 45(1):19-26
7. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–6.
8. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009;50:1109–17.
9. Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018;11:CD001903.
10. Hartling L, Hamm M, Milne A, et al. Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. Appendix E, Decision Rules for Application of the Newcastle-Ottawa Scale. Available from: https://www.ncbi.nlm.nih.gov/books/NBK92291/
11. Pires ME, Ilea A, Bourel E, Bellavoine V, Merdariu D, Berquin P, Auvin S. Ketogenic diet for infantile spasms refractory to first-line treatments: an open prospective study. Epilepsy Res. 2013 Jul;105(1-2):189-94. doi: 10.1016/j.eplepsyres.2012.11.009.
12. Dressler A, Trimmel-Schwahofer P, Reithofer E, Gröppel G, Mühlebner A, Samueli S, Grabner V, Abraham K, Benninger F, Feucht M. The ketogenic diet in infants--Advantages of early use. Epilepsy Res. 2015 Oct;116:53-8. doi: 10.1016/j.eplepsyres.2015.06.015.
13. Ismayilova N, Leung MA, Kumar R, Smith M, Williams RE. Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy. Seizure. 2018 Apr;57:5-7. doi: 10.1016/j.seizure.2018.02.014.
14. Wirrell E, Eckert S, Wong-Kisiel L, Payne E, Nickels K. Ketogenic Diet Therapy in Infants: Efficacy and Tolerability. Pediatr Neurol. 2018 May;82:13-18. doi: 10.1016/j.pediatrneurol.2017.10.018.
15. Riantarini I, Kim HD, Ko A, Kim SH, Kang HC, Lee JS, Jung DE. Short- and long-term seizure-free outcomes of dietary treatment in infants according to etiology. Seizure. 2019 Oct;71:100-104. doi: 10.1016/j.seizure.2019.06.002.
16. Armeno M, Verini A, Caballero E, Cresta A, Valenzuela GR, Caraballo R. Long-term effectiveness and adverse effects of ketogenic diet therapy in infants with drug-resistant epilepsy treated at a single center in Argentina. Epilepsy Res. 2021 Dec;178:106793. doi: 10.1016/j.eplepsyres.2021.106793.
17. Liu Y, Wan J, Gao Z, Xu L, Kong L. Ketogenic diet and growth in Chinese infants with refractory epilepsy. Asia Pac J Clin Nutr. 2021;30(1):113-121. doi: 10.6133/apjcn.202103_30(1).0014.
18. Ruiz-Herrero J, Cañedo-Villarroya E, Pérez-Sebastián I, Bernardino-Cuesta B, Pedrón-Giner C. Efficacy and safety of ketogenic dietary theraphies in infancy. A single-center experience in 42 infants less than two years of age. Seizure. 2021 Nov;92:106-111. doi: 10.1016/j.seizure.2021.08.018.
19. Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020 Jun;61(6):1261-1281. doi: 10.1111/epi.16543.
20. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000;105:E46.
21. Sourbron J, Klinkenberg S, van Kuijk SMJ, Lagae L, Lambrechts D, Braakman HMH, Majoie M. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. Childs Nerv Syst. 2020 Jun;36(6):1099-1109. doi: 10.1007/s00381-020-04578-7.
22. Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, Wan CM. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017 Dec;13(6):528-536. doi: 10.1007/s12519-017-0053-2.
23. Rusli V, Irwanto. Administering Valproic acid in epilepsy and speech delay in children. Bali Med J. 2023;12(3):2601-3.